Professional Documents
Culture Documents
Aom
Aom
GUIDELINES
Adapted from:
American Academy of Pediatrics and American Academy of Family Physicians treatment guidelines for uncomplicated
acute otitis media. Pediatrics. 2004.
OBJECTIVES
The objectives of the guideline are (1) to emphasize the requisites of diagnosis of acute otitis
media and ; (2) to evaluate current diagnostic techniques; and (23) to describe treatment
options.2
Adapted from:
LITERATURE SEARCH
AHRQ 1
Clinical Evidence
The National Guideline Clearinghouse was searched for guidelines in acute otitis media and 5
relevant guidelines were obtained. These are the 1) American Academy of Pediatrics (AAP) and
American Academy of Family Physicians (AAFP) Subcommittee on Management of Acute Otitis
Media Clinical Practice Guideline; 2) Cincinnati Childrens Hospital Medical Center Evidence
Based Clinical Practice Guideline for Medical Management of Acute Otitis Media; 3) University of
Michigan Health System Guidelines for Clinical Care (Otitis Media); 4) Scottish Intercollegiate
Guidelines Network (SIGN) and 5) Institute for Clinical Systems Improvement. The book
Evidence-Based Otitis Media by Rosenfeld and Bluestone was also reviewed. Additional
literature search strategy used MEDLINE, Cochrane Database, National Library of Medicines
PubMed database, Agency for Healthcare Research and Quality (AHRQ) Evidence Report and
Technology Assessment and Clinical Evidence by British Medical Journal were searched using
the keyword otitis media, exploded to include acute otitis media with the subheadings regarding
prevalence, diagnosis, and therapy. The search was limited to articles involving humans and
those published in English in the last fifteen years. The search yielded 4,226 articles (4222
4
pubmed, 3 cochrane, 1 AHRQ, 2 Clinical Evidence). Thirty-eight (38) abstracts were chosen and
results were further assessed for relevance. Full text articles were obtained when possible. The
chosen articles were divided as follows:
Meta-analysis 5
Randomized controlled trial 35
Non-randomized controlled study 3
Descriptive study 1
ConcensusConsensus report/ CPG 5
DEFINITION
Acute otitis media (AOM) is clinically defined as an inflammation of the middle ear with rapid
onset of signs and symptoms of less than 3 weeks duration. 3
The group recognizes that acute otitis media may progress through the following stages . These
stages are: 4
1. Stage of retraction / hyperemia/ retraction
This is the onset of disease with generalized hyperemia of the mucoperiosteum. Symptoms
include mild earache, ear fullness and fever. Otoscopy will show an erythematous and
markedly retracted eardrum.
2. Stage of exudationpre-suppuration
This stage marks the outpouring of fluid from the dilated permeable capillaries. All symptoms
are aggravated especially pain and fever. Otoscopy will reveal a red, thickened bulging
eardrum with loss of the light reflex.
5. Stage of cComplication
This stage marks the spread of the infection to beyond the middle ear.
Check stages
In developing countries, the World Health Organization (WHO) attributes 51,000 deaths per year,
in children under five years old, to otitis media. In terms of disability adjusted life years, otitis
media is comparable to meningitis, polio and trachoma. 5 (WHO 1993). The aetiologyetiology of
AOM is similar in developed and developing countries. However, complication rates (with up to
20% progressing to chronic serous otitis media or mastoiditis) are similar in developing countries
5
6
are similar to those in Europe and the USA in the 1930s and 1940s, and the pre-antibiotic era .
(Berman 1995).
7
In PGH, acute otitis media constitutes 0.9% of ENT-OPD consults.
RISK FACTORS
Host related factors (very young age, presence of allergy, immunodeficiency, presence of
craniofacial abnormalities, genetic predisposition) as well as environmental factors (upper
respiratory infection, daycare attendance, more siblings, tobacco smoke exposure,
bottlefeedingbottle feeding, pacifier, pacifier use and low socioeconomic status) are considered
risk factors in the occurrence, recurrence and persistence of middle ear disease. 8
World Health Organization. World Development Report 1993: investing in health 1993;Oxford University Press.
ORL-OPD Midyear Census Report 2005. Department of Otorhinolaryngology, Philippine General Hospital
Rosenfeld RM and Bluestone CD. Evidence-Based Otitis Media. Hamilton: B.C.Decker Inc. 1999.
.
1. To diagnose acute otitis media, the physician should confirm a history of acute onset
and evaluate for the signs and symptoms of middle ear inflammation.
Grade B Recommendation
6
e. air-fluid level or air bubbles behind the tympanic membrane OR
f. perforation with otorrhea
ANDandAND
3. 3. any one of the following:finding of:
a. fever OR
b. distinct otalgia (discomfort clearly referable to the ear(s) that results in
interference with or precludes normal activity or sleep)
American Academy of Pediatrics and American Academy of Family Physicians treatment guidelines for
uncomplicated acute otitis media. Pediatrics. 2004.
Look for diagnostic studies wherein reference standard is tympanocentesis applied on a group of patients with
varying of symptoms in a blinded way.
History of abrupt onset of otalgia/ ear tugging, irritability in an infant/ toddler, otorrhea and fever
are usually non-specific and are also found in patients with upper respiratory tract infection,
without AOM, thus clinical history alone is poorly predictive of AOM especially in younger
children.3
American Academy of Pediatrics and American Academy of Family Physicians treatment guidelines for uncomplicated
acute otitis media. Pediatrics. 2004.
To identify signs and symptoms of middle ear effusion (MEE), confirmation with the use of
pneumatic otoscopy is recommended. Findings on otoscopy include fullness/ bulging of the
tympanic membrane (and has the highest predictive value for the presence of MEE), reduced/
absent mobility and opacification or cloudiness of the tympanic membrane. When the presence
of middle ear fluid is difficult to determine, the use of tympanometry can be helpful in establishing
the diagnosis. Findings of middle ear fluid in tympanometry show a type B curve*. 9
*from PSO OME CPG
Signs and symptoms of middle ear inflammation must also be determined during otoscopy and
includes distinct erythema of the tympanic membrane and this must be differentiated from the
pink erythematous flush evoked by crying or high fever. 3
American Academy of Pediatrics and American Academy of Family Physicians treatment guidelines for
uncomplicated acute otitis media. Pediatrics. 2004.
A certain diagnosis of AOM meets the three wo all three of the criteria
enumerated in the table.mentioned above.
Grade B Recommendation
7
Bertin L. Pons G, dAthis P et al. a randomized, double blind, multicentre controlled trial of Ibuprofen
versus acetaminophen and placebo for symptoms of acute otis media in children. Fundam Clin Pharmacol.
1996; 10:387-92.
Goldman RD, Ko K, Linett LJ, Scolnik D. Antipyretic Efficacy and Safety of Ibuprofen and Acetaminophen
in Children. Ann Phramacother 2004; 38:P 146-50.
Li SF, Lacher B, Crain EF.Acetaminophen and ibuprofen dosing by parents. Pediatr Emerg Care. 2000 Dec;16(6):394-.
American Academy of Pediatrics and American Academy of Family Physicians treatment guidelines for
uncomplicated acute otitis media. Pediatrics. 2004.
Grade B Recommendation
The management of pain especially during the first 24 hours of an episode of AOM,
should be addressed, regardless of the use of antibacterial agents. The use of
Paracetamol (10-15 mkdose) or Ibuprofen ( 5-10 mkdose ) provides effective analgesia
for mild to moderate pain, is readily available and is a mainstay of pain management for
acute otitis media.10,11,12
In young children pain is a symptom that compels mothers to bring children to doctors. It
is also a gauge of clinical effectiveness.3
Grade C Recommendation
Uncomplicated acute otitis media is defined as inflammation confined to the middle ear
cleft with absence of the following: 1) severe otalgia and serious illness 2) unsatisfactory
response to initial optimal antibacterial therapy 3) associated with a confirmed or potential
suppurative complication 4) immunologically deficient patient any of whom may harbor an
unusual organism. 8
Clinicians may consider the observation option only if the following can be
assured: 1)
adequate follow-up and 2)
8
presence of an adult who will reliably observe the child, recognize signs and symptoms
of severe illness and be able to provide prompt access to medical care if improvement
does not occur. 3
Grade B recommendation
Uncomplicated acute otitis media is defined as inflammation confined to the middle ear cleft
with absence of the following: 1) severe otalgia and serious illness 2) unsatisfactory response to
initial optimal antibacterial therapy 3) associated with a confirmed or potential suppurative
complication 4) immunologically deficient patient any of whom may harbor an unusual organism.
8
Severe illness is moderate to severe otalgia or fever =>39 C. Non-severe illness is mild
otalgia and fever< 39 C in the past 24 hours. 3
4
Symptoms and oOtoscopic findings Stage 2, 3, 4 and 5. Stage 2, 3 and 4
(complication)
Identified risk factors include early age of onset (less than 6 months), attendance in day
care or crowded living conditions, low income bracket families, previous recent intake of
antibiotics, cleft palate and other craniofacial abnormalities, recurrent airway infection,
history of bottlefeedingbottle feeding, exposure to smoking, allergy, family history of
recurrent AOM in sibling or parent. 8
3.
Grade C Recommendation
Clinicians may consider the observation option only if the following can be assured:
1) adequate follow-up
9
2) presence of an adult who will reliably observe the child, recognize signs and
symptoms of severe illness and be able to provide prompt access to medical care if
improvement does not occur. 3
American Academy of Pediatrics and American Academy of Family Physicians treatment guidelines for
uncomplicated acute otitis media. Pediatrics. 2004.
Grade A Recommendation
Site local reference with regards to susceptibility and resistance of expected pathogens-
RITM study.
There are numerous medications that are effective for AOM, Amoxicillin is recommended
as a first-line therapy because of its general effectiveness when used in sufficient doses
against susceptible and intermediate resistant pneumococci, as well as its safety, low-
cost, acceptable taste, and narrow microbiologic spectrum. 3
In patients who have severe illness, and in whom additional coverage for beta-
lactamase positive Haemophilus influenzae and Moraxella catarrhalis is desired, therapy
should be initiated with high dose amoxicillin-clavulanate ( 90 mg/kg/day of amoxicillin
component, with 6.4 mg/kg/day of clavulanate in 2 divided doses)
Lee et al. Clin Infect Dis 2001; 32:14631469
American Academy of Pediatrics and American Academy of Family Physicians treatment guidelines for
uncomplicated acute otitis media. Pediatrics. 2004.
Bottenfeld G, Burch D, Hedrick J, Schaten R, Rowinski, C, Davies, J. Safety and Tolerability of a new
formulation (90 mkday divided every 12h) of amoxicillin/ clavulanate in the empiric treatment of pediatric acute
otitis media caused by drug-resistant Streptococcus pneumoniae. Pediatr Infect Dis J, 1998 17(10);963-968.
Piglansky L, Leibovitz E, Raiz S, Greenberg D, Press J, Leiberman A, Dagan R. Bacteriologic And Clinical
Efficacy Of High Dose Amoxicillin For Therapy Of Acute Otitis Media In Children. Pediatr Infect Dis J,
2003;22:40512 Vol. 22, No. 5
Dowell, SF. Acute Otitis Media: management and surveillance in an era of pneumococcal resistance- a report
from the Drug resistant Streptococcus pneumoniae Therapeutic Working Group. Pediatr Clin North Am; 18:1.
Grade C Recommendation
10
Depending on the type of allergic reaction observed, several antibiotics
can be recommended.
*Type I hypersensitivity is immediate or anaphylactic hypersensitivity. The reaction takes 15-30 minutes from
the time of exposure to the antigen.
**Non-Type I hypersensivity is not an immediate reaction and may involve other mechanisms of allergy.
American Academy of Pediatrics and American Academy of Family Physicians treatment guidelines for
uncomplicated acute otitis media. Pediatrics. 2004.
6. Duration of antibiotic treatment should depend on the age of the patient and
disease severity.
Grade A Recommendation
The optimal duration of therapy for patients with AOM is still controversial. In a
Cochrane review, the summary odds ratio (OR) for treatment outcomes at eight to 19
days in 1,524 children treated with short-acting antibiotics for five days versus eight to 10
days was 1.52, 95% CI: 1.17-1.98, but by 20 to 30 days outcomes between treatment
groups (n=2,115) were comparable (OR=1.22, 95% CI:0.98-1.54). The absolute
difference in treatment failure at 20 to 30 days suggests that at minimum 17 children
would need to be treated with the long course of short-acting antibiotics to avoid one
treatment failure. Similarity in outcomes was observed for up to three months following
therapy (OR=1.16,95% CI=0.9-1.5). Comparable outcomes were shown between
treatment with ceftriaxone or azithromycin, and more than seven days of other antibiotics.
This review suggested that five days of short-acting antibiotic is effective treatment for
uncomplicated ear infections in children. Although, in another CPG, they pointed out that
the results favoring standard 10-day course have been most significant in children
younger than 2 years and suggestive of increased efficacy in those 2 to 5 years of age.
Thus, for younger patients (< 6 years old), and for children with severe disease, a
standard 10-day course is recommended. For children, 6 years of age and older with
mild to moderate disease, a 5-7 day course is appropriate. 3,15,16
Kozyrskyj, AL; Hildes-Ripstein, GE; Longstaffe, SEA; Wincott, JL; Sitar, DS; Klassen, TP; Moffatt, MEK. Short course
antibiotics for acute otitis media [Review]. The Cochrane Database of Systematic Reviews. The Cochrane Library,
Copyright 2005, The Cochrane Collaboration, Volume (2); 2005
11
Cohen, R. Levy C. Boucherat M., Langue, J, de La Roque, F. A multicenter, randomized, double blind trial of 5 versus 10
days of antibiotic therapy for acute otitis media in young children. J Pediatr 1998 5;634-639.
American Academy of Pediatrics and American Academy of Family Physicians treatment guidelines for
uncomplicated acute otitis media. Pediatrics. 2004.
7. If the patient fails to respond to the initial management option within 48-72 hours,
the clinician must reassess the patient to look for possible complications and
exclude other causes of illness.
57.1. Ifin the patient was initially managed with observation, management
options include initiating antibacterial therapy. Look for evidence of myringotomy,i.e.
Netherlands CPG Many considerations: age, economics etc.
75.2. If the patient was initially managed with an antibacterial agent (s),
management options include 1) increasing the dose of Amoxicillin to 80-90
mkday; 2) change the antibacterial agent(s); or 3) perform myringotomy in
addition to modified antibacterial therapy
Grade C Recommendation
The time course for clinical response should be 48-72 hours. Criteria for response are
the following: 1) defervescence within 48-72 hours, 2) decreased irritability and 3)
sleeping/ eating patterns should begin to normalize. If AOM is confirmed in the patient
initially managed with observation, the clinician should begin antibacterial therapy.
Amoxicillin 40-50 mkday should be the first line of treatment (see recommendations 3
and 4).
If the patient was initially managed with an antibacterial agent (s), the clinician should
increase the Amoxicillin to 80-90 mkday17,18,19 or change the antibacterial agent(s).
Second line antibacterial agents that can be considered are summarized in the table
below. This is summarized in the table below.
American Academy of Pediatrics and American Academy of Family Physicians treatment guidelines for
uncomplicated acute otitis media. Pediatrics. 2004.
One RCT in infants aged 3 months to 1 year found no significant difference in resolution
of clinical symptoms between groups receiving myringotomy only, antibiotic only, and
myringotomy plus antibiotic, but found higher rates of persistent infection with
myringotomy only. A second RCT in children aged 212 years found no significant
difference between myringotomy and no treatment in reduction of pain at 24 hours or 7
days. A third RCT in children aged 7 months to 12 years found higher rates of initial
12
treatment failure (resolution of symptoms within 12 hours) for severe episodes of acute
otitis media treated by myringotomy and placebo compared with antibiotic. 21 These
studies do not find added benefit of myringotomy. However, myringotomy can be used to
obtain microbiological sample to guide the physician on antimicrobial therapy.
Myringotomy alone has been shown to hasten resolution of acute otitis media especially
when antibiotic treatment has failed.
Get Puhakka H
Grade A Recommendation
Complicated acute otitis media includes patients with 1) severe otalgia and serious
illness 2) unsatisfactory response to initial optimal antibacterial therapy 3) associated with
a confirmed or potential suppurative complication 4) immunologically deficient patient any
of whom may harbor an unusual organism. There is lack of evidence regarding the
management of AOM in this special group of patients and since the benefit of treating
them far outweighs the foreseen harm, the panel recommends immediate treatment.
Grade A Recommendation
Grade A Recommendation
Flynn CA, Griffin GH, Schultz, JK. Decongestants and antihistamines for acute otitis media in children. The
Cochrane Database of Systematic Reviews. The Cochrane Library. 2005
However, the panel recognizes that these agents maybe used for concomitant illness
such as allergies.
13
ALGORITHM FOR THE MANAGEMENT OF ACUTE OTITIS MEDIA
Is pain
Yes
present?
No
Treatment Options No
1. Start antibiotic therapy. Start Amoxicillin 40-50 With improvement of s/sx
2. (+/-) myringotomy with mkday
culture studies
Re-assess after 48-72
Re-assess after 48-72 hours
hours Yes
Yes
Good response
with antibiotics CONTINUE
MANAGEMENT
No
Treatment Options
1. Amoxicillin 80-90 mkday
2. Change Antibiotics
3. Myringotomy
14
References
10. Bertin L. Pons G, dAthis P et al. a randomized, double blind, multicentre controlled trial of
Ibuprofen versus acetaminophen and placebo for symptoms of acute otitis media in
children. Fundam Clin Pharmacol. 1996; 10:387-92.
11. Goldman RD, Ko K, Linett LJ, Scolnik D. Antipyretic Efficacy and Safety of Ibuprofen and
Acetaminophen in Children. Ann Phramacother 2004; 38:P 146-50.
12. Li SF, Lacher B, Crain EF.Acetaminophen and ibuprofen dosing by parents. Pediatr
Emerg Care. 2000 Dec;16(6):394-.
13. Carlos, Celia Antimicrobial Resistance Surveillance Data 1998 to 2002. DOH Committee
on Antimicrobial Resistance Surveillance
15. Kozyrskyj, AL; Hildes-Ripstein, GE; Longstaffe, SEA; Wincott, JL; Sitar, DS; Klassen, TP;
Moffatt, MEK. Short course antibiotics for acute otitis media [Review]. The Cochrane
Database of Systematic Reviews. The Cochrane Library, Copyright 2005, The Cochrane
Collaboration, Volume (2); 2005
15
17. Bottenfeld G, Burch D, Hedrick J, Schaten R, Rowinski, C, Davies, J. Safety and
Tolerability of a new formulation (90 mkday divided every 12h) of amoxicillin/ clavulanate
in the empiric treatment of pediatric acute otitis media caused by drug-resistant
Streptococcus pneumoniae. Pediatr Infect Dis J, 1998 17(10);963-968.
19. Dowell, SF. Acute Otitis Media: management and surveillance in an era of pneumococcal
resistance- a report from the Drug resistant Streptococcus pneumoniae Therapeutic
Working Group. Pediatr Clin North Am; 18:1.
20. Cincinnati Childrens Hospital Medical Center Evidence Based Clinical Practice Guideline
for Medical Management of Acute Otitis Media. October 29, 2004
22. Flynn CA, Griffin GH, Schultz, JK. Decongestants and antihistamines for acute otitis
media in children. The Cochrane Database of Systematic Reviews. The Cochrane
Library. 2005
Guidelines Reviewed
1. Institute for Clinical Systems Improvement (ICSI). Diagnosis and Treatment of Otitis
Media in Children. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI);
2004 May. 27 p. [58 references]
2. Scottish Intercollegiate Guidelines Network. Diagnosis and Management of Childhood
Otitis Media in Primary Care, A National Clinical Guideline. 2003
3. Cincinnati Childrens Hospital Medical Center Evidence Based Clinical Practice Guideline
for Medical Management of Acute Otitis Media. October 29, 2004
4. University of Michigan Health System Guidelines for Clinical Care of Otitis Media. May
2002
Search Engines/Database
16
17
Uncomplicated
AOM
The clinician
assess pain
Yes
The clinician
recommends treatment
to reduce pain
Amoxicillin at a dose of
Is observation an No Does the child have No 80-90mg/kg/day is the
appropriate initial fever >39C and/or initial antibacterial of
treatment option? severe otalgia? choice for most
children
Yes Yes
Yes
Is diagnosis of No Assess for other causes of
AOM confirmed? illness and manage
Patient ff-up as appropriately
appropriate
Yes
18
REFERENCES
3. World Health Organization. World Development Report 1993: investing in health 1993;Oxford
University Press.
5. Bertin L. Pons G, dAthis P et al. a randomized, double blind, multicentre controlled trial of
Ibuprofen versus acetaminophen and placebo for symptoms of acute otis media in children.
Fundam Clin Pharmacol. 1996; 10:387-92.
6. Li SF, Lacher B, Crain EF. Acetaminophen and ibuprofen dosing by parents. Pediatr Emerg
Care. 2000 Dec;16(6):394-7.
7. Dowell, SF. Acute Otitis Media: management and surveillance in an era of pneumococcal
resistance- a report from the Drug resistant Streptococcus pneumoniae Therapeutic Working
Group. Pediatr Clin North Am; 18:1.
8. Kozyrskyj, AL; Hildes-Ripstein, GE; Longstaffe, SEA; Wincott, JL; Sitar, DS; Klassen, TP;
Moffatt, MEK. Short course antibiotics for acute otitis media [Review]. The Cochrane Database of
Systematic Reviews. The Cochrane Library, Copyright 2005, The Cochrane Collaboration,
Volume (2); 2005
9. Glasziou PP, Del Mar CB, Sanders SL, Hayem M. Antibiotics for acute otitis media in children.
The Cochrane Database of Systematic Reviews: Reviews 2004 Issue 1 John Wiley & Sons, Ltd
Chichester, UK
10. Flynn CA, Griffin GH, Schultz JK. Decongestants and antihistamines for acute otitis media in
children. The Cochrane Database of Systematic Reviews: Reviews 2004 Issue 3 John Wiley &
Sons, Ltd Chichester, UK
12. Goldman RD, Ko K, Linett LJ, Scolnik D. Antipyretic Efficacy and Safety of Ibuprofen and
Acetaminophen in Children. Ann Phramacother 2004; 38:P 146-50.
15. Bottenfeld G, Burch D, Hedrick J, Schaten R, Rowinski, C, Davies, J. Safety and Tolerability
of a new formulation (90 mkday divided every 12h) of amoxicillin/ clavulanate in the empiric
treatment of pediatric acute otitis media caused by drug-resistant Streptococcus pneumoniae.
Pediatr Infect Dis J, 1998 17(10);963-968.
19
16. Flynn CA, Griffin GH, Schultz, JK. Decongestants and antihistamines for acute otitis media in
children. The Cochrane Database of Systematic Reviews. The Cochrane Library. 2005
17. Institute for Clinical Systems Improvement (ICSI). Diagnosis and Treatment of Otitis Media in
Children. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2004 May. 27 p.
[58 references]
18. Scottish Intercollegiate Guidelines Network. Diagnosis and Management of Childhood Otitis
Media in Primary Care, A National Clinical Guideline. 2003
19. Cincinnati Childrens Hospital Medical Center Evidence Based Clinical Practice Guideline for
Medical Management of Acute Otitis Media. October 29, 2004
20. University of Michigan Health System Guidelines for Clinical Care of Otitis Media. May 2002
22. Rosenfeld RM and Bluestone CD. Evidence-Based Otitis Media. Hamilton: B.C.Decker Inc.
1999.
20